InvestorsHub Logo
Followers 3
Posts 389
Boards Moderated 0
Alias Born 02/23/2016

Re: None

Friday, 02/03/2017 9:05:51 AM

Friday, February 03, 2017 9:05:51 AM

Post# of 81
Stemline says patient died during Phase 2 BPDCN trial

On January 18, the company received a report that a patient death had occurred. The patient had developed capillary leak syndrome, a known, sometimes fatal, and well-documented side effect of SL-401

http://thefly.com/landingPageNews.php?id=2499112&headline=STML-Stemline-says-patient-died-during-Phase--BPDCN-trial